US$ 20.26
bpc-157 human clinical trial interstitial cystitis Diagnosis of This doesn't mean BPC-157 is
Description
doi: 10.1021/acs.molpharmaceut.9b00971
Seiwerth et al., Frontiers in Pharmacology (2021) and Xing et al., Int J Mol Sci (2021)

Its primary mechanism involves upregulating VEGF (vascular endothelial growth factor), which promotes new blood vessel growth at the site of damage
TB-500 Best for: soft-tissue repair and wound-healing recovery TB-500 is the trade name for a synthetic peptide fragment (Ac-LKKTETQ, corresponding to amino acids 17-23 of the naturally occurring 43-amino-acid protein thymosin beta-4) marketed as an actin-regulating tissue-repair research compound

Molecular Formula: CHNO
